Founded by two Qualified Persons — Eric Che and Peter Mollison — Eramol is built around a firm commitment to quality, regulatory compliance, and client responsiveness. The privately owned company, devoid of private equity influence, prioritises service, delivery and innovation, allowing it to act entirely in the best interests of its clients. Operating from state‑of‑the‑art MHRA‑ and HPRA‑approved facilities in the UK and Ireland, it provides a seamless service from clinical through to commercial manufacturing

Key Products and Services
Eramol provides a comprehensive suite of services tailored to the needs of clinical trial sponsors:

• Formulation development
  – Early‑phase to late‑phase and commercial-scale formulation development for solid, liquid and capsule dosage forms.

• Placebo manufacturing
  – Customised placebo matching services to support blinded clinical trials.

• Comparator drug procurement
  – Global sourcing of commercial comparators through a validated, GDP‑compliant supplier network.

• Primary manufacturing
  – Manufacture of non‑sterile dosage forms, including tablets, capsules and oral liquids, within MHRA‑approved cleanroom facilities.

• Packaging and labelling
  – Primary and secondary packaging solutions, including bottling, blistering, kit assembly, bespoke cartoning and labelling formats such as Tear‑Off, Just‑in‑Time (JIT) and multi‑lingual booklets.

• Qualified Person (QP) release
  – UK and EU QP batch release services, with dedicated QPs assigned to every project for direct client communication.

• Importation and logistics
  – Authorised EU and UK importation services, global distribution and logistics via a network of specialist depots across key territories.

• Clinical supply chain solutions
  – End‑to‑end clinical supply management covering storage, distribution and regulatory documentation.

Eramol’s integrated service offering—from formulation and manufacturing through to packaging, QP release and global distribution—positions it as a flexible and reliable partner for both commercial and non‑commercial clinical trial sponsors. With deep industry expertise, regulatory authorisations and a commitment to tailored service, Eramol empowers clients to navigate the complexities of clinical development with efficiency and assurance.